Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Huston

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Plos Pathogens|April 26, 2024
Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiationMuhammad M Hasan, Ethan B Mattice, José E Teixeira, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Structure (London, England : 1993)|September 5, 2017
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and CoccidiosisVitul Jain, Manickam Yogavel, Haruhisa Kikuchi, et al.
Nature Communications|September 27, 2024
Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male miceJubilee Ajiboye, José E Teixeira, Makafui Gasonoo, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Plos Neglected Tropical Diseases|March 21, 2020
Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activityGretchen Ehrenkaufer, Pengyang Li, Erin E Stebbins, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
BMJ Open Quality|February 17, 2021
Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centreTimothy J Whitman, Cindy D Noyes, Andrew J Hale, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Nature Communications|April 25, 2019
A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitorsRajiv S Jumani, Muhammad M Hasan, Erin E Stebbins, et al.
Plos Pathogens|April 26, 2024
Cryptosporidium life cycle small molecule probing implicates translational repression and an Apetala 2 transcription factor in macrogamont differentiationMuhammad M Hasan, Ethan B Mattice, José E Teixeira, et al.
Journal of Medicinal Chemistry|June 2, 2023
Structure-Activity Relationship Studies of the Aryl Acetamide Triazolopyridazines against Tanner J Schubert, Edmund Oboh, Hannah Peek, et al.
Structure (London, England : 1993)|September 5, 2017
Targeting Prolyl-tRNA Synthetase to Accelerate Drug Discovery against Malaria, Leishmaniasis, Toxoplasmosis, Cryptosporidiosis, and CoccidiosisVitul Jain, Manickam Yogavel, Haruhisa Kikuchi, et al.
Nature Communications|September 27, 2024
Identification of potent and orally efficacious phosphodiesterase inhibitors in Cryptosporidium parvum-infected immunocompromised male miceJubilee Ajiboye, José E Teixeira, Makafui Gasonoo, et al.
Clinical Microbiology Reviews|April 28, 2017
Susceptibility Testing of Medically Important ParasitesAbebe Genetu Bayih, Anjan Debnath, Edward Mitre, et al.
Plos Neglected Tropical Diseases|March 21, 2020
Identification of anisomycin, prodigiosin and obatoclax as compounds with broad-spectrum anti-parasitic activityGretchen Ehrenkaufer, Pengyang Li, Erin E Stebbins, et al.
Nature Communications|June 29, 2019
Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosisChristopher S Lunde, Erin E Stebbins, Rajiv S Jumani, et al.
BMJ Open Quality|February 17, 2021
Impact and costs of a hepatitis C virus screening programme for adults hospitalised at an academic medical centreTimothy J Whitman, Cindy D Noyes, Andrew J Hale, et al.
Antimicrobial Agents and Chemotherapy|March 23, 2021
Spontaneous Selection of <i>Cryptosporidium</i> Drug Resistance in a Calf Model of InfectionMuhammad M Hasan, Erin E Stebbins, Robert K M Choy, et al.
Pageof 6